FEND

David was Professor of the Practice of Bioengineering at Harvard University in the School of Engineering & Applied Sciences from 2002 to 2019. He transitioned to an Associate in 2019 in order to lead the founding of FEND, and participate in the conceiving and growth of Next Breath, a non-profit focused on cleaning the air breathed by habitants of low- and middle-income countries where respiratory disease is the principal killer.  David is also founder of Incredible Foods, an invention for which he received his first Time Magazine Invention of the Year (2014), before receiving his second Time Invention of the Year (2020) for FEND.

David has received many international honors and awards, is a member of the National Academy of Engineering in the USA and in France, a member of the National Institute of Inventors, and a Chevalier of the Arts & Letters by the French Ministry of Culture. His recent book Creating Things That Matter (Holt 2018) won a 2018 Nautilus Book of the Year Award.

Rachel Field obtained her PhD from Columbia University in Bioengineering (2021). A co-founder of Sensory Cloud with David Edwards, with whom she studied at Harvard College, earning a bachelor’s degree in mechanical engineering in 2013, Rachel has deep experience in research, technology translation, and invention.

In addition to her work in olfaction, aerosol delivery, and implantable drug-delivery devices, Rachel received in 2014 an international award for her invention of a means of recycling computer waste in low-income settings and notably in Ghana where her invention was translated.

Peter is a global health leader combining expertise in clinical infectious diseases, academic research, product development and innovative health delivery.

Having spent roughly a decade as a physician at UCSF, a scientist at Stanford and a product developer at Gates Foundation, he is focused on integrating innovative technology into health systems to improve delivery of care.

Alex Wiltschko is a research scientist at Google Brain, focusing on building more flexible machine learning software systems, and also applications of machine learning to biology. He has helped build several machine learning libraries, including torch-autograd, and Tangent, a compiler-based autodiff library for Python at Google.

Dr. Anthony Hickey, Ph.D., is a senior research pharmacologist at RTI. Dr. Hickey has more than 30 years of academic and research experience in pulmonary biology, aerosol physics, powder dynamics, pharmacokinetics and drug disposition, formulation design, and device development.

He is an adjunct professor of biomedical engineering at the University of North Carolina at Chapel Hill School of Medicine, emeritus professor of molecular pharmaceutics at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy, and founder and president of Cirrus Pharmaceuticals, Inc.

Dr. Brownstein is the Chief Innovation Officer at Boston's Children Hospital, and a professor at Harvard Medical School. He is trained as an epidemiologist, with interests in the development of methods and data sources in public health informatics.

Dr. Brownstein has advised the World Health Organization, Institute of Medicine, the US Departments of Health and Human Services and Homeland Security, and the White House on real-time public health surveillance data.